Article
Efficacy and safety of decitabine combined with low-dose cytarabine, aclarubicin, and granulocyte colony-stimulating factor compared with standard therapy in acute myeloid leukemia patients with TP53 mutation.
Chinese medical journal - 8 Dec 2020
Chen Si-Si, Sun Qian, Cao Lan, Wu Wen-Zhong, Xie Yue, Qiao Chun, Li Jian-Yong, Qian Si-Xuan, Hong Ming
Abstract excerpt
No abstract is available from the source.
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.